CG
PRAH

Cutler Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cutler Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-56
Closed -$5K – 4955
2018
Q2 		$5K Sell
56
-700
-93% -$60.3K ﹤0.01% 3175
2018
Q1 		$62K Buy
756
+600
+385% +$53.3K 0.01% 1515
2017
Q4 		$14K Buy
156
+113
+263% +$9.4K ﹤0.01% 2902
2017
Q3 		$3K Buy
+43
New +$3.25K ﹤0.01% 4926
2017
Q2 		– Sell
-769
Closed -$53.3K – 7400
2017
Q1 		$50K Sell
769
-1,023
-57% -$60.3K ﹤0.01% 2419
2016
Q4 		$98K Sell
1,792
-221
-11% -$12.1K ﹤0.01% 1936
2016
Q3 		$113K Buy
2,013
+577
+40% +$28.3K 0.01% 1705
2016
Q2 		$59K Buy
+1,436
New +$66.2K ﹤0.01% 2200
2016
Q1 		– Sell
-51
Closed -$2.15K – 7482
2015
Q4 		$2K Buy
+51
New +$2.14K ﹤0.01% 5712

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cutler Group's PRAH Position: Q3 2018 in Review

Cutler Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2018, closing a stake of 56 shares — an estimated $5K sold.

Cutler Group first reported a position in PRAH in Q4 2015 and held it in 9 quarters. The position peaked at $113K in Q3 2016. 342 funds tracked by Wall St. Rank hold PRAH as of Q3 2018.

  • Cutler Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2018 after selling out during the quarter.
  • Cutler Group sold 56 PRA Health Sciences, Inc. shares in Q3 2018, an estimated $5K.
  • Cutler Group first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 9 quarters.
  • Cutler Group's PRA Health Sciences, Inc. position peaked at $113K in Q3 2016.
  • 342 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2018.

Based on Cutler Group's 13F filing for Q3 2018, filed 7 Nov 2018.